Clinical manifestations and recurrence rates of various forms of extragenital endometriosis

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective: This study aimed to evaluate the clinical and anamnestic data of patients with different forms of extragenital endometriosis (EGE), considering previous surgical interventions.

Materials and methods: A cross-sectional study was conducted at the V.I. Kulakov NMRC for OG&P from 2021 to 2023. The study involved 200 patients (mean age: 32.03 (7.15) years) with EGE, diagnosed using pelvic ultrasound (US) and magnetic resonance imaging (MRI). Patients were categorized into 3 groups based on the form of endometriosis: peritoneal endometriosis (PE), endometrioid cysts (EC), and deep endometriosis (DE). In cases of combined pathology, inclusion in a specific group was determined based on the most severe form of EGE. Women’s complaints were obtained through interviews, questionnaires, and comprehensive analysis of clinical and anamnestic data, including previous surgical and drug treatments.

Results: The study revealed that one in every three patients had complaints not typically associated with endometriosis. In every third case, the EC was incidentally identified using ultrasonography. When specifically questioned, 23.4% of patients with EC did not experience the characteristic pelvic pain associated with endometriosis, compared to 10.0% in the PE group and only 2.7% in the DE group. One in every three patients had undergone at least one previous surgical intervention, with 30.2% of them not receiving suppressive hormone therapy and 39.7% receiving short courses. Subsequently, the recurrence rate was 94.7% among patients who did not receive hormone therapy and 92% among those who received a short course of suppressive hormone therapy, irrespective of hormone therapy type. After previous surgical treatment for PE and EC, 48.7% of patients were subsequently diagnosed with DE. Among patients with previous surgery for EC, 41.9% experienced EC recurrence and 54.8% progressed to DE, whereas DE recurred to the same form of EGE in 85.7% of cases.

Conclusion: In one in every three cases, patients with EGE presented with complaints that were not typical of endometriosis. A targeted collection of complaints and medical history can aid in suspecting endometriosis as early as the initial outpatient visit, thereby reducing the time before diagnosis and treatment. Short courses of suppressive hormone therapy, regardless of type, do not prevent recurrence or progression of endometriosis after surgical treatment.

Texto integral

Acesso é fechado

Sobre autores

Veronika Pronina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: ver22595@yandex.ru
ORCID ID: 0000-0003-4566-4065

obstetrician-gynecologist, PhD student at the Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Rússia, Moscow

Anastasia Sokolova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: stasia0590@mail.ru
ORCID ID: 0000-0002-1197-3575

PhD, obstetrician-gynecologist at the Department of Gynecological Endocrinology, Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Rússia, Moscow

Galina Chernukha

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: c-galina1@yandex.ru
ORCID ID: 0000-0002-9065-5689

Dr. Med. Sci., Professor, Chief Researcher, obstetrician-gynecologist at the Department of Gynecological Endocrinology, Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Rússia, Moscow

Bibliografia

  1. Moradi Y., Shams-Beyranvand M., Khateri S., Gharahjeh S., Tehrani S., Varse F. et al. A systematic review on the prevalence of endometriosis in women. Indian J. Med. Res. 2021; 154(3): 446-54. https://dx.doi.org/10.4103/ijmr.IJMR_817_18.
  2. Bernuit D., Ebert A.D., Halis G., Strothmann A., Gerlinger C., Geppert K., Faustmann T. Female perspectives on endometriosis: findings from the uterine bleeding and pain women’s research study. Journal of Endometriosis. 2011; 3(2): 73-85. https://dx.doi.org/10.5301/je.2011.8525.
  3. Fuldeore M.J., Soliman A.M. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women. Gynecol. Obstet. Invest. 2017; 82(5): 453-61. https://dx.doi.org/10.1159/000452660.
  4. Pereira A., Herrero-Trujillano M., Vaquero G., Fuentes L., Gonzalez S., Mendiola A., Perez-Medina T. Clinical management of chronic pelvic pain in endometriosis unresponsive to conventional therapy. J. Pers. Med. 2022; 12(1):101. doi: 10.3390/jpm12010101.
  5. Agarwal S.K., Antunez-Flores O., Foster W.G., Hermes A., Golshan S., Soliman A.M. et al. Real-world characteristics of women with endometriosis-related pain entering a multidisciplinary endometriosis program. BMC Womens Health. 2021; 21(1): 19. https://dx.doi.org/10.1186/s12905-020-01139-7.
  6. Urteaga I., McKillop M., Elhadad N. Learning endometriosis phenotypes from patient-generated data. NPJ Digit. Med. 2020; 3: 88. doi: 10.1038/ s41746-020-0292-9.
  7. Sinaii N., Plumb K., Cotton L., Lambert A., Kennedy S., Zondervan K., Stratton P. Differences in characteristics among 1,000 women with endometriosis based on extent of disease. Fertil. Steril. 2008; 89(3): 538-45. https://dx.doi.org/10.1016/ j.fertnstert.2007.03.069.
  8. Nisenblat V., Bossuyt P.M., Farquhar C., Johnson N., Hull M.L. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst. Rev. 2016; 2(2): CD009591. https://dx.doi.org/10.1002/ 14651858.CD009591.
  9. Becker C.M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L. et al.; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum. Reprod. Open. 2022; 2022(2): hoac009. doi: 10.1093/hropen/hoac009.
  10. Méndez Fernández R., Barrera Ortega J. Magnetic resonance imaging of pelvic endometriosis. Radiologia. 2017; 59(4): 286-96. https://dx.doi.org/10.1016/ j.rx.2017.02.002.
  11. Khashchenko E.P., Uvarova E.V., Fatkhudinov T.K., Chuprynin V.D., Asaturova A.V., Kulabukhova E.A. et al. Endometriosis in adolescents: diagnostics, clinical and laparoscopic features. J. Clin. Med. 2023; 12(4): 1678. https://dx.doi.org/10.3390/jcm12041678.
  12. Maciel C., Ferreira H., Djokovic D., Kyaw Tun J., Keckstein J., Rizzo S., Manganaro L. MRI of endometriosis in correlation with the #Enzian classification: applicability and structured report. Insights Imaging. 2023; 14(1): 120. https://dx.doi.org/10.1186/s13244-023-01466-x.
  13. Manganaro L., Fierro F., Tomei A., Irimia D., Lodise P., Sergi M.E. et al. Feasibility of 3.0T pelvic MR imaging in the evaluation of endometriosis. Eur. J. Radiol. 2012; 81(6): 1381-7. https://dx.doi.org/10.1016/j.ejrad.2011.03.049.
  14. Thomeer M.G., Steensma A.B., van Santbrink E.J., Willemssen F.E., Wielopolski P.A., Hunink M.G. et al. Can magnetic resonance imaging at 3.0-Tesla reliably detect patients with endometriosis? Initial results. J. Obstet. Gynaecol. Res. 2014; 40(4): 1051-8. https://dx.doi.org/10.1111/ jog.12290.
  15. Fruchart M., El Idrissi F., Lamer A., Belarbi K., Lemdani M., Zitouni D., Guinhouya B.C. Identification of early symptoms of endometriosis through the analysis of online social networks: A social media study. Digit. Health. 2023; 9: 20552076231176114. https://dx.doi.org/10.1177/20552076231176114.
  16. Chapron C., Lafay-Pillet M.C., Santulli P., Bourdon M., Maignien C., Gaudet-Chardonnet A. et al. A new validated screening method for endometriosis diagnosis based on patient questionnaires. EClinicalMedicine. 2022; 44: 101263. https://dx.doi.org/10.1016/j.eclinm.2021.101263.
  17. Chen C.X., Carpenter J.S., Gao X., Toh E., Dong Q., Nelson D.E. et al. Associations between dysmenorrhea symptom-based phenotypes and vaginal microbiome: a pilot study. Nurs. Res. 2021; 70(4): 248-55. https://dx.doi.org/ 10.1097/NNR.0000000000000510.
  18. Chapron C., Santulli P., de Ziegler D., Noel J.C., Anaf V., Streuli I. et al. Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis. Hum. Reprod. 2012; 27(3): 702-11. https://dx.doi.org/10.1093/humrep/der462.
  19. Khan K.N., Kitajima M., Fujishita A., Hiraki K., Matsumoto A., Nakashima M., Masuzaki H. Pelvic pain in women with ovarian endometrioma is mostly associated with coexisting peritoneal lesions. Hum. Reprod. 2013; 28(1): 109-18. https://dx.doi.org/10.1093/humrep/ des364.
  20. Perelló M., Martínez-Zamora M.A., Torres X., Munrós J., Llecha S., De Lazzari E. et al. Markers of deep infiltrating endometriosis in patients with ovarian endometrioma: a predictive model. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017; 209: 55-60. https://dx.doi.org/10.1016/j.ejogrb.2015.11.024.
  21. Nirgianakis K., Ma L., McKinnon B., Mueller M.D. Recurrence patterns after surgery in patients with different endometriosis subtypes: a long-term hospital-based cohort study. J. Clin. Med. 2020; 9(2): 496. https://dx.doi.org/10.3390/jcm9020496.
  22. Sibiude J., Santulli P., Marcellin L., Borghese B., Dousset B., Chapron C. Association of history of surgery for endometriosis with severity of deeply infiltrating endometriosis. Obstet. Gynecol. 2014; 124(4): 709-17. doi: 10.1097/AOG.0000000000000464.
  23. Shakiba K., Bena J.F., McGill K.M., Minger J., Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet. Gynecol. 2008; 111(6): 1285-92. https://dx.doi.org/10.1097/AOG.0b013e3181758ec6.
  24. Bazot M., Bharwani N., Huchon C., Kinkel K., Cunha T.M., Guerra A. et al. European society of urogenital radiology (ESUR) guidelines: MR imaging of pelvic endometriosis. Eur. Radiol. 2017; 27(7): 2765-75. https://dx.doi.org/10.1007/s00330-016-4673-z.
  25. von Theobald P., Cottenet J., Iacobelli S., Quantin C. Epidemiology of endometriosis in France: a large, nation-wide study based on hospital discharge data. Biomed. Res. Int. 2016; 2016: 3260952. https://dx.doi.org/10.1155/2016/ 3260952.
  26. Blum S., Fasching P.A., Hildebrandt T., Lermann J., Heindl F., Born T. et al. Comprehensive characterization of endometriosis patients and disease patterns in a large clinical cohort. Arch. Gynecol. Obstet. 2022; 305(4): 977-84. https://dx.doi.org/10.1007/s00404-021-06200-w.
  27. Piriyev E., Schiermeier S., Römer T. Coexistence of endometriomas with extraovarian endometriosis and adhesions. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 263: 20-4. doi: 10.1016/j.ejogrb.2021.05.044.
  28. Пронина В.А., Думановская М.Р., Чернуха Г.Е. Оптимизация принципов ранней диагностики эндометриоза на основе оценки коморбидности и клинической манифестации. Акушерство и гинекология. 2023; 4: 87-96. [Pronina V.A., Dumanovskaya M.R., Chernukha G.E. Principles of early diagnosis of endometriosis based on the assessment of comorbidity and clinical manifestations. Obstetrics and Gynecology. 2023; (4): 87-96. (in Russian)]. https://dx.doi.org/10.18565/aig.2023.9.
  29. Nirgianakis K., Ma L., McKinnon B., Mueller M.D. Recurrence patterns after surgery in patients with different endometriosis subtypes: a long-term hospital-based cohort study. J. Clin. Med. 2020; 9(2): 496. https://dx.doi.org/10.3390/jcm9020496
  30. Xu B., Lin L., Pan Y., Chen P., Ye C., Zhao L. et al. The clinical picture and fecundity of primary and recurrent ovarian endometriosis with family history: a retrospective analysis. J. Clin. Med. 2023; 12(5): 1758. https://dx.doi.org/ 10.3390/jcm12051758.
  31. Heinemann K., Imthurn B., Marions L., Gerlinger C., Becker K., Moehner S., Faustmann T. Safety of dienogest and other hormonal treatments for endometriosis in real-world clinical practice (VIPOS): a large noninterventional study. Adv. Ther. 2020; 37(5): 2528-37. https://dx.doi.org/10.1007/ s12325-020-01331-z.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2. Fig. 1. Frequency and structure of forms of endometriosis in patients included in the study (n=200)

Baixar (334KB)
Metadados
3. Fig. 2. Frequency of previous surgical treatment of endometriosis in different age groups

Baixar (50KB)
Metadados
4. Fig. 3. Structure of the leading complaints of patients with endometriosis

Baixar (237KB)
Metadados

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies